📰 Initial Registration Statement News
Page 3 - Initial Registration Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Initial Registration Statement. Real-time updates on events, politics, business and more.
November 14, 2022
BOSTON, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, Inc. ("Yumanity" or the "Company") (Nasdaq: YMTX), a clinical-stage biopharmaceutical company, today announced financial results for
October 10, 2022
/PRNewswire/ -- Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in...
October 4, 2022
/PRNewswire/ -- Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in...
December 7, 2021
The following managements discussion and analysis of financial condition and results of operations provides information that management believes is relevant to an assessment and understanding of our... | December 7, 2021
June 12, 2021
STANDBY EQUITY DISTRIBUTION AGREEMENT THIS STANDBY EQUITY DISTRIBUTION AGREEMENT dated as of June ___, 2021 is made by and between YA II PN, LTD., a Cayman Islands exempt... | June 12, 2021